Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Shanghai Labway Clinical Laboratory Co Ltd
Net Income (Common)
Shanghai Labway Clinical Laboratory Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
|
Net Income (Common)
-¥141.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Net Income (Common)
¥9.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Net Income (Common)
¥3.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Net Income (Common)
¥2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
See Also
What is Shanghai Labway Clinical Laboratory Co Ltd's Net Income (Common)?
Net Income (Common)
-141.6m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Labway Clinical Laboratory Co Ltd's Net Income (Common) amounts to -141.6m CNY.